News
TIACA and Pharma.Aero Join Forces to Prepare Air Cargo Industry for COVID-19 Vaccine
The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation...
News
FDA Accepts Biogens Aducanumab Biologics License Application for Alzheimer’s Disease with Priority Review
Biogen and Eisai, Co., Ltd. announced that the U.S. FDA has accepted the Biologics License Application (BLA) for aducanumab, an investigational treatment for Alzheimer’s...
Press Releases
Regeneron Announces FDA Accepts Evinacumab BLA for Priority Review as Treatment for Patients with HoFH
Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA has accepted for Priority Review a Biologics License Application (BLA) for evinacumab as an adjunct to...
Drug Research
Caprion-HistoGeneX, Viroclinics-DDL Announce COVID-19 Research Partnership
Caprion-HistoGeneX and Viroclinics-DDL announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target...
News
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development program, Project Lightspeed, against SARS-CoV-2, were published online...
News
Gilead Submits New Drug Application to U.S. FDA for Veklury for the Treatment of COVID-19
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. FDA for Veklury® (remdesivir), an investigational antiviral for...
Press Releases
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-1
Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
